Cancer Center

CTRC commences enrollment in Phase 2 trial of REOLYSIN combination for SCC lung cancer
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. The CTRC has started patient enrollment in a US Phase 2 clinical trial using intravenous …

Read more on News-Medical-Net

Related posts

• The Race is Run One Step at a Time: Every Woman’s Guide to Taking Charge of Breast Cancer and My Personal Story
• CT scan cancer call to cut use
• The Cancer-Fighting Kitchen: Nourishing, Big-Flavor Recipes for Cancer Treatment and Recovery
• US Cancer Costs Double in Nearly 20 Years
• Many Doctors Not Using Colon Cancer Test Properly